Search

everythinglearnresearchcommunity

for

Search:↓

Stress can trigger or worsen alopecia areata.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Understanding proteins linked to PCOS symptoms can improve diagnosis and treatment.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

iPSCs are promising for studying and treating COVID-19.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

EPDS and MS might share an immune-related cause.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Serum clusterin may play a key role in the inflammation and immune response in post-adolescent acne.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Future acne treatments should aggressively target inflammation to prevent scarring.

Lifestyle changes can help manage androgenetic alopecia.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.